drugset / Trial / NCT05843422
A First-in-Human Study of QY211 Gel in Adult Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase Ia/Ib,Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of Single and Multiple Topical Doses of QY211 Gel in Healthy Chinese Subjects and Patients with Mild to Moderate Atopic Dermatitis
Timeline
- Start
- 2023-03-01
- Primary completion
- 2024-10-23
- Completion
- 2024-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QY211 | Unknown | 0.1 % | Topical |
| Subject | QY211 | Unknown | 0.3 % | Topical |
| Subject | QY211 | Unknown | 0.8 % | Topical |
| Subject | QY211 | Unknown | 1.5 % | Topical |